Works matching AU Bogdanov, Alina


Results: 21
    1
    2

    Effectiveness of the 2023–2024 Omicron XBB.1.5-containing mRNA COVID-19 Vaccine (mRNA-1273.815) in Preventing COVID-19–related Hospitalizations and Medical Encounters Among Adults in the United States.

    Published in:
    Open Forum Infectious Diseases, 2024, v. 11, n. 12, p. 1, doi. 10.1093/ofid/ofae695
    By:
    • Kopel, Hagit;
    • Araujo, Andre B;
    • Bogdanov, Alina;
    • Zeng, Ni;
    • Winer, Isabelle;
    • Winer-Jones, Jessamine P;
    • Lu, Tianyi;
    • Marks, Morgan A;
    • Bonafede, Machaon;
    • Nguyen, Van Hung;
    • Martin, David;
    • Mansi, James A
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Comparative Effectiveness of the Bivalent (Original/Omicron BA.4/BA.5) mRNA COVID-19 Vaccines mRNA-1273.222 and BNT162b2 Bivalent in Adults with Underlying Medical Conditions in the United States.

    Published in:
    Vaccines, 2024, v. 12, n. 10, p. 1107, doi. 10.3390/vaccines12101107
    By:
    • Kopel, Hagit;
    • Nguyen, Van Hung;
    • Bogdanov, Alina;
    • Winer, Isabelle;
    • Boileau, Catherine;
    • Ducruet, Thierry;
    • Zeng, Ni;
    • Winer-Jones, Jessamine P.;
    • Esposito, Daina B.;
    • Bausch-Jurken, Mary;
    • Beck, Ekkehard;
    • Bonafede, Machaon;
    • Mansi, James A.
    Publication type:
    Article
    14
    15
    16
    17
    18

    Early use of erenumab in US real-world practice.

    Published in:
    Cephalalgia Reports, 2021, v. 4, p. 1, doi. 10.1177/25158163211020419
    By:
    • Bogdanov, Alina;
    • Chia, Victoria;
    • Bensink, Mark;
    • Urman, Robert;
    • Fischer, Lauren;
    • Rasmussen, Soeren;
    • Szekely, Christine;
    • Kallenbach, Lee
    Publication type:
    Article
    19
    20
    21